Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis research 2022-07, Vol.215, p.1-4
Hauptverfasser:	Mithoowani, Siraj, Moffat, Karen A., Gupta, Akash, Carlino, Stephen A., Crowther, Mark A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulant reversal Anticoagulants Blood coagulation tests Factor Xa inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	4
container_issue
container_start_page	1
container_title	Thrombosis research
container_volume	215
creator	Mithoowani, Siraj Moffat, Karen A. Gupta, Akash Carlino, Stephen A. Crowther, Mark A.
description
doi_str_mv	10.1016/j.thromres.2022.05.005
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2666549606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384822002584</els_id><sourcerecordid>2666549606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-75b5a153134bc33a4a83ec85e4595f11195d5af1d2da7e8326dfc4f4d5f83c993</originalsourceid><addsrcrecordid>eNqFkEmPEzEQhS0EYsLAXxj5yKUb7919A43YpEhcQOJmVezqiSP3gt2dkBs_HUeZ4cqpFr1XT_URcsdZzRk37w71sk_TkDDXgglRM10zpp-RDW-brhKqEc_JhjHVVbJV7Q15lfOBMd7wTr8kN1LrlimjN-TPdjrRYYro1giJnjA87Be6xxlSGCmMS6h-AoWc4Zypg5EGj2XZn-kMSyhtpqew7KmLYQwOYjzTMMxTWoqVwhx-ww4udzxN4Qhpus4-rQ804hFjfk1e9BAzvnmst-THp4_f779U22-fv95_2FZOdO1SNXqngWvJpdo5KUFBK9G1GpXudM95-ctr6LkXHhpspTC-d6pXXvetdF0nb8nb6905Tb9WzIsdQnYYI4w4rdkKY4xWnWGmSM1V6tKUc8LezikMkM6WM3uhbw_2ib690LdM20K_GO8eM9bdgP6f7Ql3Eby_CsrjeAyYbHYFokMfErrF-in8L-MvTLedAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2666549606</pqid></control><display><type>article</type><title>Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels</title><source>Elsevier ScienceDirect Journals</source><creator>Mithoowani, Siraj ; Moffat, Karen A. ; Gupta, Akash ; Carlino, Stephen A. ; Crowther, Mark A.</creator><creatorcontrib>Mithoowani, Siraj ; Moffat, Karen A. ; Gupta, Akash ; Carlino, Stephen A. ; Crowther, Mark A.</creatorcontrib><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2022.05.005</identifier><identifier>PMID: 35580465</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Anticoagulant reversal ; Anticoagulants ; Blood coagulation tests ; Factor Xa inhibitors</subject><ispartof>Thrombosis research, 2022-07, Vol.215, p.1-4</ispartof><rights>2022 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c298t-75b5a153134bc33a4a83ec85e4595f11195d5af1d2da7e8326dfc4f4d5f83c993</citedby><cites>FETCH-LOGICAL-c298t-75b5a153134bc33a4a83ec85e4595f11195d5af1d2da7e8326dfc4f4d5f83c993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0049384822002584$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35580465$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mithoowani, Siraj</creatorcontrib><creatorcontrib>Moffat, Karen A.</creatorcontrib><creatorcontrib>Gupta, Akash</creatorcontrib><creatorcontrib>Carlino, Stephen A.</creatorcontrib><creatorcontrib>Crowther, Mark A.</creatorcontrib><title>Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><subject>Anticoagulant reversal</subject><subject>Anticoagulants</subject><subject>Blood coagulation tests</subject><subject>Factor Xa inhibitors</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkEmPEzEQhS0EYsLAXxj5yKUb7919A43YpEhcQOJmVezqiSP3gt2dkBs_HUeZ4cqpFr1XT_URcsdZzRk37w71sk_TkDDXgglRM10zpp-RDW-brhKqEc_JhjHVVbJV7Q15lfOBMd7wTr8kN1LrlimjN-TPdjrRYYro1giJnjA87Be6xxlSGCmMS6h-AoWc4Zypg5EGj2XZn-kMSyhtpqew7KmLYQwOYjzTMMxTWoqVwhx-ww4udzxN4Qhpus4-rQ804hFjfk1e9BAzvnmst-THp4_f779U22-fv95_2FZOdO1SNXqngWvJpdo5KUFBK9G1GpXudM95-ctr6LkXHhpspTC-d6pXXvetdF0nb8nb6905Tb9WzIsdQnYYI4w4rdkKY4xWnWGmSM1V6tKUc8LezikMkM6WM3uhbw_2ib690LdM20K_GO8eM9bdgP6f7Ql3Eby_CsrjeAyYbHYFokMfErrF-in8L-MvTLedAA</recordid><startdate>20220701</startdate><enddate>20220701</enddate><creator>Mithoowani, Siraj</creator><creator>Moffat, Karen A.</creator><creator>Gupta, Akash</creator><creator>Carlino, Stephen A.</creator><creator>Crowther, Mark A.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220701</creationdate><title>Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels</title><author>Mithoowani, Siraj ; Moffat, Karen A. ; Gupta, Akash ; Carlino, Stephen A. ; Crowther, Mark A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-75b5a153134bc33a4a83ec85e4595f11195d5af1d2da7e8326dfc4f4d5f83c993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulant reversal</topic><topic>Anticoagulants</topic><topic>Blood coagulation tests</topic><topic>Factor Xa inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mithoowani, Siraj</creatorcontrib><creatorcontrib>Moffat, Karen A.</creatorcontrib><creatorcontrib>Gupta, Akash</creatorcontrib><creatorcontrib>Carlino, Stephen A.</creatorcontrib><creatorcontrib>Crowther, Mark A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mithoowani, Siraj</au><au>Moffat, Karen A.</au><au>Gupta, Akash</au><au>Carlino, Stephen A.</au><au>Crowther, Mark A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2022-07-01</date><risdate>2022</risdate><volume>215</volume><spage>1</spage><epage>4</epage><pages>1-4</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>35580465</pmid><doi>10.1016/j.thromres.2022.05.005</doi><tpages>4</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0049-3848
ispartof	Thrombosis research, 2022-07, Vol.215, p.1-4
issn	0049-3848 1879-2472
language	eng
recordid	cdi_proquest_miscellaneous_2666549606
source	Elsevier ScienceDirect Journals
subjects	Anticoagulant reversal Anticoagulants Blood coagulation tests Factor Xa inhibitors
title	Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A45%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low%20molecular%20weight%20heparin%20anti-Xa%20assays%20can%20identify%20patients%20with%20clinically%20important%20apixaban%20and%20rivaroxaban%20drug%20levels&rft.jtitle=Thrombosis%20research&rft.au=Mithoowani,%20Siraj&rft.date=2022-07-01&rft.volume=215&rft.spage=1&rft.epage=4&rft.pages=1-4&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2022.05.005&rft_dat=%3Cproquest_cross%3E2666549606%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2666549606&rft_id=info:pmid/35580465&rft_els_id=S0049384822002584&rfr_iscdi=true